TCGX
4 rounds tracked since 12 January 2026.
- Rounds
- 4
- Led
- 2
- Capital in these rounds
- $807M
Sectors
Countries
Rounds
- Vaderis TherapeuticsLeadDevelops targeted therapies for rare vascular diseases $152MSeries B · 11 Aug
- Ollin BiosciencesLeadDevelops OLN324 therapy for diabetic macular edema and wet age-related macular degeneration. $330MSeries B · 24 Jun
- Adcendo ApSDevelops antibody-drug conjugate cancer therapies through a clinical-stage pipeline. $75MSeries C · 14 Apr
- MiradorDevelops clinical-stage therapies for immuno-fibrotic diseases through a multi-asset pipeline $250MSeries B · 12 Jan
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise